Document is current
Any future updates will be listed below
-
Authors
Zheng, Linyi
Li, Yuqiang
Güngör, Cenap
Ge, Heming
-
Funding
Funding for this research was provided by:
Universitätsklinikum Hamburg-Eppendorf (UKE)
- License Information
-
More Information
Article History
Received: 26 June 2025
Accepted: 9 October 2025
First Online: 27 October 2025
Declarations
:
: The GWAS summary statistics utilized for AILDs and antibodies against EBV in this study were extracted from publicly available ethically reviewed publications. Specifically, the UK Biobank approved the release of summary statistics related to the UK Biobank. The FinnGen Biobank GWAS, executed by the FinnGen team, was sanctioned by the FinnGen Steering Committee, with summary statistics available for public downloads on the official website. All these data are de-identified, freely downloadable, and accessible without restriction.Given that our research entailed no collection of fresh primary data and was conducted entirely online, we did not require any new ethical approval.
: Not applicable.
: The authors declare no competing interests.
